The story of Viagra presents a nuanced case for stakeholders in the drug sector. While initially a phenomenal success, generating vast sums, the exclusivity lapse and the subsequent entry of off-brand versions have https://knockoff465017.therainblog.com/40263446/the-little-copyright-and-the-pharmaceutical-industry-a-hazardous-investment